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The case in favor
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The polarization of views on how best to exploit new information from the Human Genome
Project for medicine reflects our ignorance of the genetic architecture underlying common diseases:
are susceptibility alleles common or rare, neutral or deleterious, few or many? Single-nucleotide
polymorphism (SNP) technology is almost in place to dissect such diseases and to create a personal-
ized medicine, but success is critically dependent on the biology and “Nature to be commanded must
be obeyed” (Francis Bacon, 1620, Novum Organum). 
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(a) Illustration of the common variant/common disease and multilocus/multiallele hypotheses (see text for details). Shaded
symbols indicate carriers of a disease or trait; open symbols are non-carriers. (b) Inverse relationship between allele
frequency and phenotypic effect, as postulated by Sewall Wright [10]. The arbitrary division between alleles with small
(polygene), intermediate (oligogene) or large (major) effects is based on Morton [11]; λS, relative risk to sibs.
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λs =1.1 λs =7.5
(a) 
Multilocus/multiallele hypothesis
Common disease/common variant hypothesis
(b)
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Table 1
Summary of allelic heterogeneity in support of the common disease/common variant or multiallele/multilocus hypotheses
Disease type Locus Allele Trait Frequency Effect Comments
(a) Common disease/common variant hypothesis
Cardiovascular APOE *E4 Alzheimer 0.10-0.15 Early onset Allele present in primates and all world 
disease (Caucasian) populations; possible interaction with
dietary fats; may account for 20% of 
Alzheimer disease
Age-related 0.10-0.15 Decreased risk Well-established protective effect on 
macular age-related macular degeneration
degeneration 
Cardiovascular 0.10-0.15 Increased risk Accounts for 10-16% of plasma 
disease cholesterol variance (western 
populations); increases risk of 
cardiovascular disease (odds ratio 
approximately 1.5) 
F5 R506Q Venous 0.02-0.08 Increased risk Carriers have around 10% lifetime risk
thrombosis for significant venous thrombosis
Metabolic/ PPARG P12A Type 2 diabetes 0.85 Increased risk Relative risk 1.25
nutritional mellitus (Caucasian)
CAPN10 Haplotypes Type 2 diabetes 0.03-0.29 (low Increased risk in Complex risk haplotypes that may 
112 and 121 mellitus to high risk 121/112 haplotype include several SNPs, including 
populations) heterozygotes CAPN10-g.4852G/A (UCSNP-43)
HFE C282Y Haemochromatosis 0.05 Around 40% risk High frequency in Caucasians, low in 
(Caucasian) for homozygotes Asiatics (suggesting admixture), so it may
be a recent mutation (less than 50,000
years ago)
Cancer ELAC2 S217L Prostate cancer 0.30 and 0.04 Increased risk Odds ratio 2.4-3.1
and A541T (Caucasian)
BRCA2 N372H Breast cancer 0.22-0.29 Increased risk Relative risk = 1.31 for HH compared to 
(Caucasian) NN genotypes
Infectious/ MHC class I HLA-B*2702, Ankylosing 0.09 Increased risk Odds ratio approximately 170, mechanism
inflammatory 04, 05 spondylitis (Caucasian) unclear; also associated with reactive 
arthritis and uveitis; about 2% of B27-
positive carriers develop ankylosing
spondylitis
MHC class II DQB1*0302- Type 1 diabetes 0.05 Increased risk Around 10% of heterozygotes for these
DRB1*0401/ mellitus (European) high risk haplotypes develop type 1 
DQB1*0201- diabetes mellitus; relative risk 
approximately 20
DRB1*03
IL12B 3′ UTR Type 1 diabetes 0.79 Increased risk Interaction with HLA; increased 
allele 1 mellitus (Caucasian) expression of IL12B in vitro
G6PD A- G6PD deficiency Approximately Decreased risk of High allele frequency proposed to be 
(V68M/N126D) 0.20 (West severe malaria due to balancing selection
African)
HBB HbC (E6K) Anaemia 0.09 (West Decreased risk of High allele frequency proposed to be 
(homozygotes) African) severe malaria due to balancing selection
CCR5 ∆32-CCR5 HIV-1 0.09 Decreased HIV-1 Recent origin - estimated approximately 
transmission (Caucasian) transmission 700 years ago [13]
Developmental PDGFRA Promoter Neural tube 0.23 Increased risk for At least six polymorphic sites within 
H1/H2α defect (Caucasian) sporadic neural each haplotype
haplotypes tube defect
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Disease type Locus Allele Trait Frequency Effect Comments
(b) Multilocus/multiallele hypothesis 
Cardiovascular LDLR > 735 alleles Coronary artery All rare, except in Increased risk of 
disease isolate or founder coronary artery 
populations disease
APOB > 24 alleles Coronary artery R3500Q 0.002, Increased risk of Single common R3500Q allele
disease remainder rare coronary artery 
disease
Cancer BRCA1 > 483 alleles Familial breast- All rare, except in Increased risk 
ovarian cancer isolate or founder 
populations
BRCA2 > 404 alleles Familial breast All rare, except in Increased risk Common N372H allele (frequency 
cancer isolate or founder approximately 0.25) with relative 
populations risk 1.31
MLH1 > 143 alleles Hereditary non- All rare Increased risk
polyposis colorectal 
cancer (HNPCC)
MSH2 > 108 alleles Hereditary non- All rare Increased risk
polyposis colorectal 
cancer (HNPCC)
P53 > 144 alleles Multiple cancers All rare Increased risk
Neurosensory ABCA4 > 350 alleles Stargardt disease, Most rare, G863A  Increased risk
retinitis pigmentosa allele approximately  
0.014 (Europeans)
RHO > 88 alleles Retinitis pigmentosa, All rare Increased risk
congenital stationary 
night blindness
GJB2 > 45 alleles Non-syndromic Most rare, 30delG Increased risk 30delG absent from non-European 
deafness allele around 0.015 populations
(Europeans)
Metabolic/ CFTR > 963 alleles Cystic fibrosis Most rare, 
nutritional ∆F508 accounts for Increased risk ∆F508 allele recent 
approximately 70% - estimated to have arisen 3,000 
of cystic fibrosis years ago [14] 
alleles in Caucasians
Data are from the Online Mendelian inheritance in Man database [30].
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Locus heterogeneity in Mendelian disorders. The diagram shows the diversity of disease loci in Mendelian forms of blindness.
A rough relationship between tissue and physiological complexity and the number of identified disease loci can be discerned.
Data are from the Online Mendelian Inheritance in Man [30] and RetNet [31] databases. RP, retinitis pigmentosa; Usher,
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